Organon and Merck are facing industry headwinds and market drawdowns following Organon's spin-off from Merck.
3 reports, 1 independent
Updated Aug 20
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Organon and Merck are facing industry headwinds and market drawdowns following Organon's spin-off from Merck.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Organon shares returned -8.2% on August 12, 2025, while the Zacks Medical Services industry lost 2.5%.Sub-event
Organon and Merck are experiencing industry headwinds and market drawdowns.1 source
Keep exploring
The entities involved
Related events
Coverage
Newest first; wire copies grouped- StockStory1 Healthcare Stock Worth Investigating and 2 Facing Challenges From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the ros
- StockStory3 of Wall Street’s Favorite Stocks We Find Risky Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain
- Unknown outlet